Antidepressants and pediatric depression--the risk of doing nothing

N Engl J Med. 2004 Oct 14;351(16):1598-601. doi: 10.1056/NEJMp048228.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Adverse Drug Reaction Reporting Systems
  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Child
  • Cognitive Behavioral Therapy
  • Combined Modality Therapy
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / psychology
  • Depressive Disorder / therapy
  • Drug Labeling / legislation & jurisprudence
  • Fluoxetine / adverse effects
  • Fluoxetine / therapeutic use
  • Government Regulation
  • Humans
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Suicide Prevention*
  • Suicide* / trends
  • United States / epidemiology
  • United States Food and Drug Administration

Substances

  • Antidepressive Agents
  • Serotonin Uptake Inhibitors
  • Fluoxetine